HMGA1 facilitates tumor progression through regulating Wnt/β-catenin pathway in endometrial cancer
Authors:
- 1 August 2016
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 82, 312-318
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- MicroRNA-21 Promotes Oral Cancer Invasion via the Wnt/β-Catenin Pathway by Targeting DKK2Pathology and Oncology Research, 2013
- HMGA1: A Master Regulator of Tumor Progression in Triple-Negative Breast Cancer CellsPLOS ONE, 2013
- A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related componentsScientific Reports, 2013
- MicroRNA-137, an HMGA1 Target, Suppresses Colorectal Cancer Cell Invasion and Metastasis in Mice by Directly Targeting FMNL2Gastroenterology, 2013
- HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinomaHistopathology, 2012
- HMGA1 Induces Intestinal Polyposis in Transgenic Mice and Drives Tumor Progression and Stem Cell Properties in Colon Cancer CellsPLOS ONE, 2012
- Lynch Syndrome—Related Endometrial Carcinomas Show a High Frequency of Nonendometrioid Types and of High FIGO Grade Endometrioid TypesInternational Journal of Surgical Pathology, 2009
- Sox9 Inhibits Wnt Signaling by Promoting β-Catenin Phosphorylation in the NucleusJournal of Biological Chemistry, 2009
- RETRACTED ARTICLE: Critical Role of the HMGI(Y) Proteins in Adipocytic Cell Growth and DifferentiationMolecular and Cellular Biology, 2001
- High-Mobility-Group Chromosomal Proteins: Architectural Components That Facilitate Chromatin Function1996